Reported Reactions

Devices › Light source, endoscope, xenon arc

Device brand name · Xenon light source

VISERA Pro XENON LIGHT SOURCE: medical device reports filed with FDA

630 reports name it, 2014–2026. Manufacturer given most often on reports: Shirakawa Olympus. Product code GCT.

630
device reports naming the brand
0% of all MAUDE reports · about 51 a year
70
reports, 12 months to August 2026
108 in the 12 months before
99.8%
classified as malfunction
94.1% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 630 reports that name the brand "VISERA Pro XENON LIGHT SOURCE" (xenon light source), received between February 2014 and August 2026; the manufacturer given most often on reports is Shirakawa Olympus. Spellings of one product vary from report to report.

70 reports arrived in the 12 months to August 2026, down 35% from 108 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (99.8%) and injury (0.2%); across all light source, endoscope, xenon arc reports (product code GCT) death is recorded in 0.2% and malfunction in 94.1%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are electrical /electronic property problem (22.7%), no device output (13.8%) and failure to power up (10.2%). The patient problems coded most often are no patient involvement. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

01020Sep 2021: 5Oct 2021: 4Nov 2021: 11Dec 2021: 102022Jan 2022: 10Feb 2022: 8Mar 2022: 13Apr 2022: 8May 2022: 13Jun 2022: 10Jul 2022: 11Aug 2022: 7Sep 2022: 2Oct 2022: 10Nov 2022: 13Dec 2022: 122023Jan 2023: 9Feb 2023: 9Mar 2023: 17Apr 2023: 7May 2023: 3Jun 2023: 7Jul 2023: 8Aug 2023: 10Sep 2023: 9Oct 2023: 7Nov 2023: 5Dec 2023: 102024Jan 2024: 11Feb 2024: 12Mar 2024: 15Apr 2024: 12May 2024: 3Jun 2024: 7Jul 2024: 8Aug 2024: 8Sep 2024: 9Oct 2024: 8Nov 2024: 3Dec 2024: 102025Jan 2025: 20Feb 2025: 9Mar 2025: 14Apr 2025: 9May 2025: 7Jun 2025: 6Jul 2025: 5Aug 2025: 8Sep 2025: 6Oct 2025: 4Nov 2025: 5Dec 2025: 72026Jan 2026: 12Feb 2026: 4Mar 2026: 11Apr 2026: 11May 2026: 6Jun 2026: 2Jul 2026: 0Aug 2026: 2

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0591172014: 320142020: 4720202021: 10820212022: 11720222023: 10120232024: 10620242025: 10020252026: 482026

Event type and report source

Event type, as classified on the report

Death0%0
Injury0.2%1
Malfunction99.8%629
Other0%0
Not given0%0

Who filed the report

Manufacturer report100%630
Voluntary report0%0
User facility report0%0
Distributor report0%0
Not given0%0

Grey bar: all 2,381 reports carrying product code GCT. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Electrical /electronic property probleman electrical or electronic problem14322.7%8%
No device output8713.8%4.6%
Failure to power up6410.2%4.6%
Activation failure416.5%3.1%
No visual prompts/feedback375.9%1.9%
Output problem345.4%2.9%
Breakthe device broke335.2%2.6%
Display or visual feedback problem294.6%2.2%
Erratic or intermittent display233.7%5.5%
Poor quality image182.9%10.1%
Defective devicethe device was defective172.7%1.4%
Power problem172.7%1%
No display/image142.2%19%
Thermal decomposition of device132.1%1.4%
Flare or flash91.4%0.5%
Optical problem81.3%1.7%
Communication or transmission problemthe device could not communicate or transmit61%2.1%
Overheating of device61%1.3%
Activation problem50.8%0.7%
Mechanical problema mechanical problem50.8%0.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
No patient involvement10.2%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureVISERA Pro XENON LIGHT SOURCEProduct code GCTAll MAUDE reports
Reports6302,38126,136,888
Share of that pool—26.5%0%
Classified as death, per 1,000 reports029
Classified as injury0.2%3.7%36.2%
Classified as malfunction99.8%94.1%62.3%
Filed by the manufacturer100%97.8%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code GCT

BrandReportsLatest 12 monthsClassified as death
Evis Lucera Elite Xenon Light Source7633370.1%
X8000 Lightsource96300%
Visera Xenon Light Source233280%
Visera 4k Uhd Xenon Light Source2871010%
X7000 Xenon Lightsource32100%
L9000 Lightsource38500%
Visera Elite Xenon Light Source2,1984780%
Halogen Light Source459550%
Spacemaker Preperitoneal Dist Balloon61200%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about VISERA Pro XENON LIGHT SOURCE reports

How many FDA reports name VISERA Pro XENON LIGHT SOURCE?

630 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 70 in the latest 12 months.

What kinds of events are reported?

malfunction (99.8%) and injury (0.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

electrical /electronic property problem (22.7%), no device output (13.8%), failure to power up (10.2%), activation failure (6.5%) and no visual prompts/feedback (5.9%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that VISERA Pro XENON LIGHT SOURCE was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.